353 related articles for article (PubMed ID: 23484892)
21. Escalating doses of C1 esterase inhibitor (CINRYZE) for prophylaxis in patients with hereditary angioedema.
Bernstein JA; Manning ME; Li H; White MV; Baker J; Lumry WR; Davis-Lorton MA; Jacobson KW; Gower RG; Broom C; Fitts D; Schranz J
J Allergy Clin Immunol Pract; 2014; 2(1):77-84. PubMed ID: 24565773
[TBL] [Abstract][Full Text] [Related]
22. Safety of C1-esterase inhibitor in acute and prophylactic therapy of hereditary angioedema: findings from the ongoing international Berinert patient registry.
Busse P; Bygum A; Edelman J; Lumry W; Machnig T; Martinez-Saguer I; Rojavin M
J Allergy Clin Immunol Pract; 2015; 3(2):213-9. PubMed ID: 25609333
[TBL] [Abstract][Full Text] [Related]
23. Effect of time to treatment on response to C1 esterase inhibitor concentrate for hereditary angioedema attacks.
Craig TJ; Rojavin MA; Machnig T; Keinecke HO; Bernstein JA
Ann Allergy Asthma Immunol; 2013 Sep; 111(3):211-5. PubMed ID: 23987198
[TBL] [Abstract][Full Text] [Related]
24. Fixed-Dose Subcutaneous C1-Inhibitor Liquid for Prophylactic Treatment of C1-INH-HAE: SAHARA Randomized Study.
Lumry WR; Martinez-Saguer I; Yang WH; Bernstein JA; Jacobs J; Moldovan D; Riedl MA; Johnston DT; Li HH; Tang Y; Schranz J; Lu P; Vardi M; Farkas H;
J Allergy Clin Immunol Pract; 2019; 7(5):1610-1618.e4. PubMed ID: 30682573
[TBL] [Abstract][Full Text] [Related]
25. Safety of a C1-inhibitor concentrate in pregnant women with hereditary angioedema.
Fox J; Vegh AB; Martinez-Saguer I; Wuillemin WA; Edelman J; Williams-Herman D; Rojavin M; Rosenberg T
Allergy Asthma Proc; 2017 May; 38(3):216-221. PubMed ID: 28441992
[TBL] [Abstract][Full Text] [Related]
26. C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks--final results of the I.M.P.A.C.T.2 study.
Craig TJ; Bewtra AK; Bahna SL; Hurewitz D; Schneider LC; Levy RJ; Moy JN; Offenberger J; Jacobson KW; Yang WH; Eidelman F; Janss G; Packer FR; Rojavin MA; Machnig T; Keinecke HO; Wasserman RL
Allergy; 2011 Dec; 66(12):1604-11. PubMed ID: 21884533
[TBL] [Abstract][Full Text] [Related]
27. Recombinant Human C1-Esterase Inhibitor to Treat Acute Hereditary Angioedema Attacks in Adolescents.
Baker JW; Reshef A; Moldovan D; Harper JR; Relan A; Riedl MA
J Allergy Clin Immunol Pract; 2017; 5(4):1091-1097. PubMed ID: 28202404
[TBL] [Abstract][Full Text] [Related]
28. Safety and Usage of C1-Inhibitor in Hereditary Angioedema: Berinert Registry Data.
Riedl MA; Bygum A; Lumry W; Magerl M; Bernstein JA; Busse P; Craig T; Frank MM; Edelman J; Williams-Herman D; Feuersenger H; Rojavin M;
J Allergy Clin Immunol Pract; 2016; 4(5):963-71. PubMed ID: 27286778
[TBL] [Abstract][Full Text] [Related]
29. Efficacy, pharmacokinetics, and safety of subcutaneous C1-esterase inhibitor as prophylaxis in Japanese patients with hereditary angioedema: Results of a Phase 3 study.
Fukuda T; Yamagami K; Kawahata K; Suzuki Y; Sasaki Y; Miyagi T; Jacobs I; Lawo JP; Glassman F; Akama H; Hide M; Ohsawa I
Allergol Int; 2023 Jul; 72(3):451-457. PubMed ID: 36858856
[TBL] [Abstract][Full Text] [Related]
30. Assessment of inhibitory antibodies in patients with hereditary angioedema treated with plasma-derived C1 inhibitor.
Farkas H; Varga L; Moldovan D; Obtulowicz K; Shirov T; Machnig T; Feuersenger H; Edelman J; Williams-Herman D; Rojavin M
Ann Allergy Asthma Immunol; 2016 Nov; 117(5):508-513. PubMed ID: 27788880
[TBL] [Abstract][Full Text] [Related]
31. Recombinant human C1 esterase inhibitor for the treatment of hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE).
Sabharwal G; Craig T
Expert Rev Clin Immunol; 2015 Mar; 11(3):319-27. PubMed ID: 25669442
[TBL] [Abstract][Full Text] [Related]
32. Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema.
Zuraw BL; Busse PJ; White M; Jacobs J; Lumry W; Baker J; Craig T; Grant JA; Hurewitz D; Bielory L; Cartwright WE; Koleilat M; Ryan W; Schaefer O; Manning M; Patel P; Bernstein JA; Friedman RA; Wilkinson R; Tanner D; Kohler G; Gunther G; Levy R; McClellan J; Redhead J; Guss D; Heyman E; Blumenstein BA; Kalfus I; Frank MM
N Engl J Med; 2010 Aug; 363(6):513-22. PubMed ID: 20818886
[TBL] [Abstract][Full Text] [Related]
33. Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema.
Lumry WR; Craig T; Zuraw B; Longhurst H; Baker J; Li HH; Bernstein JA; Anderson J; Riedl MA; Manning ME; Keith PK; Levy DS; Caballero T; Banerji A; Gower RG; Farkas H; Lawo JP; Pragst I; Machnig T; Watson DJ
J Allergy Clin Immunol Pract; 2018; 6(5):1733-1741.e3. PubMed ID: 29391286
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of recombinant human C1 esterase inhibitor for the treatment of severe hereditary angioedema attacks.
Li HH; Reshef A; Baker JW; Harper JR; Relan A
Allergy Asthma Proc; 2017 Nov; 38(6):456-461. PubMed ID: 28874235
[TBL] [Abstract][Full Text] [Related]
35. Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study.
Lumry WR; Zuraw B; Cicardi M; Craig T; Anderson J; Banerji A; Bernstein JA; Caballero T; Farkas H; Gower RG; Keith PK; Levy DS; Li HH; Magerl M; Manning M; Riedl MA; Lawo JP; Prusty S; Machnig T; Longhurst H;
Orphanet J Rare Dis; 2021 Feb; 16(1):86. PubMed ID: 33588897
[TBL] [Abstract][Full Text] [Related]
36. Long-Term Outcomes with Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema Attacks.
Craig T; Zuraw B; Longhurst H; Cicardi M; Bork K; Grattan C; Katelaris C; Sussman G; Keith PK; Yang W; Hébert J; Hanzlikova J; Staubach-Renz P; Martinez-Saguer I; Magerl M; Aygören-Pürsün E; Farkas H; Reshef A; Kivity S; Neri S; Crisan I; Caballero T; Baeza ML; Hernandez MD; Li H; Lumry W; Bernstein JA; Hussain I; Anderson J; Schwartz LB; Jacobs J; Manning M; Levy D; Riedl M; Christiansen S; Feuersenger H; Pragst I; Mycroft S; Pawaskar D; Jacobs I;
J Allergy Clin Immunol Pract; 2019; 7(6):1793-1802.e2. PubMed ID: 30772477
[TBL] [Abstract][Full Text] [Related]
37. Recombinant human C1 esterase inhibitor (Conestat alfa) for prophylaxis to prevent attacks in adult and adolescent patients with hereditary angioedema.
Valerieva A; Caccia S; Cicardi M
Expert Rev Clin Immunol; 2018 Sep; 14(9):707-718. PubMed ID: 30021471
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of C1 esterase inhibitor concentrate in treatment of cutaneous attacks of hereditary angioedema.
Bork K; Craig TJ; Bernstein JA; Feuersenger H; Machnig T; Staubach P
Allergy Asthma Proc; 2015; 36(3):218-24. PubMed ID: 25803207
[TBL] [Abstract][Full Text] [Related]
39. [EFFICACY, PHARMACOKINETICS, PHARMACODYNAMICS, AND SAFETY OF INTRAVENOUS C1 INHIBITOR FOR LONG-TERM PROPHYLAXIS AND TREATMENT OF BREAKTHROUGH ATTACKS IN JAPANESE SUBJECTS WITH HEREDITARY ANGIOEDEMA: A PHASE 3 OPEN-LABEL STUDY].
Fukunaga A; Morita E; Miyagi T; Eto K; Shimizu A; Kagami S; Yamamoto H; Vardi M; Tang Y; Wang Y; Hide M
Arerugi; 2020; 69(3):192-203. PubMed ID: 32435020
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of Different Medical Therapies for the Treatment of Acute Laryngeal Attacks of Hereditary Angioedema due to C1-esterase Inhibitor Deficiency.
Bork K; Bernstein JA; Machnig T; Craig TJ
J Emerg Med; 2016 Apr; 50(4):567-80.e1. PubMed ID: 26826769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
